In this Issue:
Fostamatinib disappoints in phase III RA study
AS or DISH in royal Egyptian mummies?
All-cause mortality and infection rates in tofacitinib studies
Abatacept in lupus nephritis
Rituximab vs azathioprine in vasculitis
Rituximab treatment of relapse in AAV
Bisphosphonates in arthroplasty
Adalimumab in giant cell arteritis
Sustained remission with etanercept tapering in early RA
Identifying patients predisposed to develop early SSc
Please login below to download this issue (PDF)